KIM FOREST ENTERPRISE CO., LTD. — Investor Relations & Filings
Kim Forest Enterprise Co., Ltd. specializes in precision medicine and molecular diagnostics, providing integrated solutions for clinical research and healthcare. The company offers a "One Stop Solution" encompassing experimental consultation, laboratory equipment supply, and bioinformatics analysis. Key products and services include Next-Generation Sequencing (NGS), PCR systems, ELISA readers, and high-content imaging systems. The company focuses on genetic testing for cancer screening, hereditary diseases, and personalized health management. By synthesizing genomic data with clinical insights, Kim Forest facilitates biomarker identification and the development of optimized treatment strategies. Its portfolio also extends to customized enzymes, drug screening technologies, and precision nutrition, supporting the advancement of personalized medicine through comprehensive technical expertise and reliable diagnostic reporting.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年04月內部人持股異動(事後) | 2026-05-05 | Chinese | |
| 115年04月董事會成員及持股 | 2026-05-05 | Chinese | |
| 公告本公司115年第一季財務報告董事會 預計召開日期為115年05月08日 | 2026-04-30 | Chinese | |
| 114年第4季財務報告書 — 202504_6645_AIC.pdf | 2026-04-21 | Chinese | |
| 114年第4季財務報告書 — 202504_6645_AIA.pdf | 2026-04-21 | Chinese | |
| 114年第4季財務報告書 — 202504_6645_AI3.pdf | 2026-04-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41459706 | 115年04月內部人持股異動(事後) | 2026-05-05 | Chinese | ||
| 41457341 | 115年04月董事會成員及持股 | 2026-05-05 | Chinese | ||
| 39887117 | 公告本公司115年第一季財務報告董事會 預計召開日期為115年05月08日 | 2026-04-30 | Chinese | ||
| 34695803 | 114年第4季財務報告書 — 202504_6645_AIC.pdf | 2026-04-21 | Chinese | ||
| 34695802 | 114年第4季財務報告書 — 202504_6645_AIA.pdf | 2026-04-21 | Chinese | ||
| 34695801 | 114年第4季財務報告書 — 202504_6645_AI3.pdf | 2026-04-21 | Chinese | ||
| 34695800 | 114年第4季財務報告書 — 202504_6645_AI1.pdf | 2026-04-21 | Chinese | ||
| 34695799 | 114年第4季財務報告書 — 202503_6645_AI1.pdf | 2026-04-21 | Chinese | ||
| 34695798 | 114年第4季財務報告書 — 202502_6645_AI1.pdf | 2026-04-21 | Chinese | ||
| 34695797 | 114年第4季財務報告書 — 202501_6645_AI1.pdf | 2026-04-21 | Chinese | ||
| 34690456 | 114年年報及股東會資料 — 2026_6645_20260522F17.pdf | 2026-04-20 | Chinese | ||
| 34690455 | 114年年報及股東會資料 — 2025_6645_20260522FE4.pdf | 2026-04-20 | English | ||
| 34690454 | 114年年報及股東會資料 — 2025_6645_20260522F04.pdf | 2026-04-20 | Chinese | ||
| 34690442 | 114年年報及股東會資料 — 2026_6645_20260522F02.pdf | 2026-04-20 | Chinese | ||
| 34690417 | 114年年報及股東會資料 — 2026_6645_20260522F13.pdf | 2026-04-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CALIWAY BIOPHARMACEUTICALS CO., LTD.
Develops small-molecule therapeutics for medical aesthetics…
|
6919 | TW | Professional, scientific and te… |
|
CALIX LIMITED
Develops industrial carbon capture and sustainable mineral …
|
CXL | AU | Professional, scientific and te… |
|
CAMBIUM BIO LIMITED
Clinical-stage developer of cellular therapies for ophthalm…
|
CMB | AU | Professional, scientific and te… |
|
CAMBRIDGE COGNITION HOLDINGS PLC
Develops digital solutions and a platform for CNS clinical …
|
COG | GB | Professional, scientific and te… |
|
CanBas Co.,Ltd.
A clinical-stage biopharmaceutical company developing novel…
|
4575 | JP | Professional, scientific and te… |
|
Captor Therapeutics S.A.
Develops Targeted Protein Degradation therapies for cancer …
|
CTX | PL | Professional, scientific and te… |
|
Cardiff Oncology, Inc.
A clinical-stage biotech developing cancer therapies that i…
|
CRDF | US | Professional, scientific and te… |
|
Cardio Diagnostics Holdings, Inc.
Develops AI-powered epigenetic and genetic tests for early …
|
CDIO | US | Professional, scientific and te… |
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory therapi…
|
CRDL | CA | Professional, scientific and te… |
|
CASSAVA SCIENCES INC
Clinical-stage biotech developing treatments for Central Ne…
|
SAVA | US | Professional, scientific and te… |
KIM FOREST ENTERPRISE CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52599/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52599 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52599 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52599 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52599}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KIM FOREST ENTERPRISE CO., LTD. (id: 52599)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.